Literature DB >> 20139068

Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells.

Jinglei Cai1, Wen Li, Huanxing Su, Dajiang Qin, Jiayin Yang, Fan Zhu, Jianyong Xu, Wenzhi He, Xiangpeng Guo, Krystyna Labuda, Anja Peterbauer, Susanne Wolbank, Mei Zhong, Zhiyuan Li, Wutian Wu, Kwok-Fai So, Heinz Redl, Lingwen Zeng, Miguel Angel Esteban, Duanqing Pei.   

Abstract

The umbilical cord and placenta are extra-embryonic tissues of particular interest for regenerative medicine. They share an early developmental origin and are a source of vast amounts of cells with multilineage differentiation potential that are poorly immunogenic and without controversy. Moreover, these cells are likely exempt from incorporated mutations when compared with juvenile or adult donor cells such as skin fibroblasts or keratinocytes. Here we report the efficient generation of induced pluripotent stem cells (iPSCs) from mesenchymal cells of the umbilical cord matrix (up to 0.4% of the cells became reprogrammed) and the placental amniotic membrane (up to 0.1%) using exogenous factors and a chemical mixture. iPSCs from these 2 tissues homogeneously showed human embryonic stem cell (hESC)-like characteristics including morphology, positive staining for alkaline phosphatase, normal karyotype, and expression of hESC-like markers including Nanog, Rex1, Oct4, TRA-1-60, TRA-1-80, SSEA-3, and SSEA-4. Selected clones also formed embryonic bodies and teratomas containing derivatives of the 3 germ layers, and could as well be readily differentiated into functional motor neurons. Among other things, our cell lines may prove useful for comparisons between iPSCs derived from multiple tissues regarding the extent of the epigenetic reprogramming, differentiation ability, stability of the resulting lineages, and the risk of associated abnormalities.

Entities:  

Mesh:

Year:  2010        PMID: 20139068      PMCID: PMC2857000          DOI: 10.1074/jbc.M109.086389

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  Comparative characterization of cultured human term amnion epithelial and mesenchymal stromal cells for application in cell therapy.

Authors:  Grozdana Bilic; Steffen M Zeisberger; Ajit S Mallik; Roland Zimmermann; Andreas H Zisch
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

2.  Generation of induced pluripotent stem cells using recombinant proteins.

Authors:  Hongyan Zhou; Shili Wu; Jin Young Joo; Saiyong Zhu; Dong Wook Han; Tongxiang Lin; Sunia Trauger; Geoffery Bien; Susan Yao; Yong Zhu; Gary Siuzdak; Hans R Schöler; Lingxun Duan; Sheng Ding
Journal:  Cell Stem Cell       Date:  2009-04-23       Impact factor: 24.633

3.  A fresh look at iPS cells.

Authors:  Shinya Yamanaka
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

4.  Generation of induced pluripotent stem cells from human blood.

Authors:  Yuin-Han Loh; Suneet Agarwal; In-Hyun Park; Achia Urbach; Hongguang Huo; Garrett C Heffner; Kitai Kim; Justine D Miller; Kitwa Ng; George Q Daley
Journal:  Blood       Date:  2009-03-18       Impact factor: 22.113

5.  Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.

Authors:  John T Dimos; Kit T Rodolfa; Kathy K Niakan; Laurin M Weisenthal; Hiroshi Mitsumoto; Wendy Chung; Gist F Croft; Genevieve Saphier; Rudy Leibel; Robin Goland; Hynek Wichterle; Christopher E Henderson; Kevin Eggan
Journal:  Science       Date:  2008-07-31       Impact factor: 47.728

6.  Induced pluripotent stem cells generated without viral integration.

Authors:  Matthias Stadtfeld; Masaki Nagaya; Jochen Utikal; Gordon Weir; Konrad Hochedlinger
Journal:  Science       Date:  2008-09-25       Impact factor: 47.728

7.  Mouse meningiocytes express Sox2 and yield high efficiency of chimeras after nuclear reprogramming with exogenous factors.

Authors:  Dajiang Qin; Yi Gan; Kaifeng Shao; Hao Wang; Wen Li; Tao Wang; Wenzhi He; Jianyong Xu; Yu Zhang; Zhaohui Kou; Lingwen Zeng; Guoqing Sheng; Miguel A Esteban; Shaorong Gao; Duanqing Pei
Journal:  J Biol Chem       Date:  2008-09-29       Impact factor: 5.157

Review 8.  Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders.

Authors:  Stormy J Chamberlain; Xue-Jun Li; Marc Lalande
Journal:  Neurogenetics       Date:  2008-09-13       Impact factor: 2.660

9.  Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.

Authors:  Jeong Beom Kim; Holm Zaehres; Guangming Wu; Luca Gentile; Kinarm Ko; Vittorio Sebastiano; Marcos J Araúzo-Bravo; David Ruau; Dong Wook Han; Martin Zenke; Hans R Schöler
Journal:  Nature       Date:  2008-06-29       Impact factor: 49.962

10.  Human induced pluripotent stem cells free of vector and transgene sequences.

Authors:  Junying Yu; Kejin Hu; Kim Smuga-Otto; Shulan Tian; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2009-03-26       Impact factor: 47.728

View more
  73 in total

1.  Human AB serum for generation of mesenchymal stem cells from human chorionic villi: comparison with other source and other media including platelet lysate.

Authors:  A Poloni; G Maurizi; F Serrani; S Mancini; G Discepoli; A L Tranquilli; R Bencivenga; P Leoni
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

2.  Generation of induced pluripotent stem cells from urine.

Authors:  Ting Zhou; Christina Benda; Sarah Duzinger; Yinghua Huang; Xingyan Li; Yanhua Li; Xiangpeng Guo; Guokun Cao; Shen Chen; Lili Hao; Yau-Chi Chan; Kwong-Man Ng; Jenny Cy Ho; Matthias Wieser; Jiayan Wu; Heinz Redl; Hung-Fat Tse; Johannes Grillari; Regina Grillari-Voglauer; Duanqing Pei; Miguel A Esteban
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

Review 3.  Biological characteristics of stem cells from foetal, cord blood and extraembryonic tissues.

Authors:  Hassan Abdulrazzak; Dafni Moschidou; Gemma Jones; Pascale V Guillot
Journal:  J R Soc Interface       Date:  2010-08-25       Impact factor: 4.118

Review 4.  Musculoskeletal tissue engineering with human umbilical cord mesenchymal stromal cells.

Authors:  Limin Wang; Lindsey Ott; Kiran Seshareddy; Mark L Weiss; Michael S Detamore
Journal:  Regen Med       Date:  2011-01       Impact factor: 3.806

5.  Mesenchymal stromal cells from human perinatal tissues: From biology to cell therapy.

Authors:  Karen Bieback; Irena Brinkmann
Journal:  World J Stem Cells       Date:  2010-08-26       Impact factor: 5.326

6.  Generation of systemic lupus erythematosus-specific induced pluripotent stem cells from urine.

Authors:  Yuyu Chen; Rongping Luo; Yong Xu; Xiujuan Cai; Wuxian Li; Kuibi Tan; Jianrong Huang; Yong Dai
Journal:  Rheumatol Int       Date:  2013-02-22       Impact factor: 2.631

Review 7.  A poor imitation of a natural process: a call to reconsider the iPSC engineering technique.

Authors:  Yemin Zhang; Lin Yao; Xiya Yu; Jun Ou; Ning Hui; Shanrong Liu
Journal:  Cell Cycle       Date:  2012-10-31       Impact factor: 4.534

Review 8.  Implantation of human umbilical cord mesenchymal stem cells for ischemic stroke: perspectives and challenges.

Authors:  Yingchen Li; Guoheng Hu; Qilai Cheng
Journal:  Front Med       Date:  2014-12-09       Impact factor: 4.592

9.  Stem cell-based interventions for the prevention and treatment of germinal matrix-intraventricular haemorrhage in preterm infants.

Authors:  Olga Romantsik; Matteo Bruschettini; Alvaro Moreira; Bernard Thébaud; David Ley
Journal:  Cochrane Database Syst Rev       Date:  2019-09-24

10.  Comparison of different protocols for neural differentiation of human induced pluripotent stem cells.

Authors:  Ali Salimi; Samad Nadri; Marzieh Ghollasi; Khosro Khajeh; Masoud Soleimani
Journal:  Mol Biol Rep       Date:  2014-01-29       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.